As presented in Figure 1, in patients with CLD, strongly elevated GH plasma levels and decreased hepatic responsiveness to GH are observed, which result in low IGF1, IGF2, IGFBP3 and ALS plasma levels. This evidence concerns the gene IGF2 and amyotrophic lateral sclerosis.